AstraZeneca

Asia
Pharma

China's BCI nod, AZ, Astellas—Fierce Pharma Asia

China approved the world's first commercial brain-computer interface. AZ expands cell therapy capabilities in China. Astellas ended a bispecific deal.
Angus Liu Mar 20, 2026 8:00am
AstraZeneca

AZ to build cell therapy supply hub, R&D center in Shanghai

Mar 19, 2026 10:20am
AstraZeneca Joshua Jackson Gritty Get Body Checked Against Cancer campaign

AZ recruits Joshua Jackson, Gritty to cancer screening push

Mar 11, 2026 1:00pm
FDA conference hall
Favicon Fierce Biotech

FDA to end 9-month adcomm hiatus with review of AZ cancer drugs

Mar 6, 2026 11:16am
Alert

FDA rejection letters flag data concerns for AZ, GSK biologics

Mar 3, 2026 11:30am
more expensive
Favicon Fierce Biotech

China is no longer licensing 'bargain basement': analyst

Feb 24, 2026 5:07pm